Gastrointestinal Cancers. Malignant neoplasms of digestive organs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A definitive physician diagnosis of one of the following gastrointestinal cancers: Esophagus, Stomach, Small intestine, Large intestine (colon and rectum), Pancreas, Liver, or Bile ducts At least basic reading and writing literacy Not being enrolled in any other ongoing interventional research studies at this treatment center Informed consent to participate in this study Must not have communication deficits related to vision or hearing Must have at least four remaining cycles of chemotherapy At least three months must have elapsed since the initial cancer diagnosis Patients must be aware of their cancer diagnosis Patients must not be undergoing treatment with anti-anxiety or anti-depressant medications In the pre-intervention assessment, participants must score below 75% on the treatment adherence questionnaire and have anxiety and depression scores greater than 7 Age 30-70 years old
Exclusion criteria
Exclusion criteria: Change in Treatment Status Withdrawal of Informed Consent Failure to attend a maximum of two educational sessions Emergence of Unforeseen Circumstances for patient Worsening of Disease or Death
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The adherence to treatment score in the Chronic Diseases Treatment Adherence Questionnaire. Timepoint: immediately before the start of the intervention and one month after the final intervention session. Method of measurement: Chronic Diseases Treatment Adherence Questionnaire.;The anxiety score in the Hospital Anxiety and Depression Scale (HADS). Timepoint: immediately before the start of the intervention and one month after the final intervention session. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;The Depression score in the Hospital Anxiety and Depression Scale (HADS). Timepoint: immediately before the start of the intervention and one month after the final intervention session. Method of measurement: Hospital Anxiety and Depression Scale (HADS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Arak University of Medical Sciences